Mice given the higher dose showed significantly superior running capacity 10 days following treatment, with increased insulin sensitivity being noted by the 7-day marker
Pearson correlations examined relationships between thalamic GSH (left and right thalamus, analysed separately) and clinical variables within the migraine group (five variables: disease duration, attack frequency, VAS, MIDAS, HIT-6) and within the TTH group (four variables: disease duration, attack frequency, VAS, HIT-6
What Practitioners Report Practitioners using this stack in clinical settings typically describe it in three functional phases: (1) a 4-week GHK-Cu loading phase to build tissue-level copper-tripeptide availability before introducing sermorelin, (2) a concurrent 12-week phase combining nightly sermorelin with GHK-Cu on a 5-days-on/2-days-off schedule, and (3) a maintenance phase reassessing IGF-1 levels at 90 days to guide sermorelin dose titration
The earlier one could intervene, the better
